Advertisement
Research Article| Volume 40, ISSUE 2, P239-246, February 2004

Acute non-selective β-adrenergic blockade reduces prolonged frequency-adjusted Q–T interval (QTc) in patients with cirrhosis

      Abstract

      Background/Aims: Earlier studies have shown a prolonged frequency-adjusted Q–T interval (QTc>0.440 s1/2) in a substantial fraction of patients with cirrhosis. The effect of β-blockade on QTc is unknown, and its determination was the aim of the study.
      Methods: Seventeen patients with cirrhosis received 80 mg propranolol orally during a haemodynamic investigation with measurements at baseline and 90 min after propranolol ingestion.
      Results: β-Blockade reduced cardiac output (−21%, P<0.001), heart rate (−20%, P<0.001), and the hepatic venous pressure gradient (HVPG, −17%, P<0.02). The mean QTc=0.460 s1/2 was prolonged compared to 0.410 s1/2 in age-matched controls (P<0.01). Whereas QTc decreased during β-blockade in the cirrhotic patients (from 0.460 to 0.440 s1/2, P<0.01), no effect was found in the subgroup with normal QTc (0.429 vs. 0.422 s1/2, ns), and a reduction was seen in the patients with prolonged QTc (from 0.488 to 0.456 s1/2, P<0.01). The percentage decrease in QTc was related to the reduction in HVPG (r=0.48, P=0.03) and cardiac output (r=0.56, P=0.02).
      Conclusions: Acute non-selective β-blockade reduces prolonged QTc towards normal values in patients with cirrhosis. The clinical significance of QTc reduction in arrhythmia is a topic for future research.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Groszmann R.J.
        Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences.
        Hepatology. 1994; 20: 1359-1363
        • Henriksen J.H.
        • Fuglsang S.
        • Bendtsen F.
        • Christensen E.
        • Møller S.
        Arterial compliance in patients with cirrhosis.
        Am J Physiol. 2001; 280: G584-G594
        • Møller S.
        • Bendtsen F.
        • Henriksen J.H.
        Effect of volume expansion on systemic haemodynamics and central and arterial blood volume in cirrhosis.
        Gastroenterology. 1995; 109: 1917-1925
        • Schrier R.W.
        • Arroyo V.
        • Bernardi M.
        • Epstein M.
        • Henriksen J.H.
        • Rodes J.
        Peripheral artery vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
        Hepatology. 1988; 8: 1151-1157
        • Laffi G.
        • Lagi A.
        • Cipriani M.
        • Barletta G.
        • Bernardi L.
        • Fattorini L.
        • et al.
        Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites.
        Hepatology. 1996; 24: 1063-1067
        • Ma Z.
        • Lee S.S.
        Cirrhotic cardiomyopathy: getting to the heart of the matter.
        Hepatology. 1996; 24: 451-459
        • Bernardi M.
        • Rubboli A.
        • Trevisani F.
        • Cancellieri C.
        • Ligabue A.
        • Baraldini M.
        • Gasbarrini G.
        Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis.
        Hepatology. 1991; 12: 207-216
        • Liu H.Q.
        • Lee S.S.
        Cardiopulmonary dysfunction in cirrhosis.
        J Gastroenterol Hepatol. 1999; 14: 600-608
        • Valeriano V.
        • Funaro S.
        • Lionetti R.
        • Riggio O.
        • Pulcinelli G.
        • Fiore P.
        • et al.
        Modification of cardiac function in cirrhotic patients with and without ascites.
        Am J Gastroenterol. 2000; 95: 3026-3028
        • Møller S.
        • Henriksen J.H.
        Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.
        Heart. 2002; 87: 9-15
        • Ma Z.
        • Miyamoto A.
        • Lee S.S.
        Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats.
        Gastroenterology. 1996; 110: 1191-1198
        • Bernardi M.
        • Calandra S.
        • Colantoni A.
        • Trevisani F.
        • Raimondo M.L.
        • Sica G.
        • et al.
        QT interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors.
        Hepatology. 1998; 27: 28-34
        • Estruch R.
        • Fernandez-Sola J.
        • Sacanella E.
        • Pare C.
        • Rubin E.
        • Urbano-Marquez A.
        Relationship between cardiomyopathy and liver disease in chronic alcoholism.
        Hepatology. 1995; 22: 532-538
        • Mohamed R.
        • Forsey P.R.
        • Davies M.K.
        • Neuberger J.M.
        Effect of liver transplantation on Q–T interval prolongation and autonomic dysfunction in end-stage liver disease.
        Hepatology. 1996; 23: 1128-1134
        • Day C.P.
        • James O.F.
        • Butler T.J.
        • Campbell R.W.
        QT prolongation and sudden cardiac death in patients with alcoholic liver disease.
        Lancet. 1993; 341: 1423-1428
        • Ward C.A.
        • Ma Z.
        • Lee S.S.
        • Giles W.R.
        Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis.
        Am J Physiol (Gastrointest). 1997; 273: G537-G544
        • Henriksen J.H.
        • Fuglsang S.
        • Bendtsen F.
        • Christensen E.
        • Møller S.
        Dyssynchronous electrical and mechanical systole in patients with cirrhosis.
        J Hepatol. 2002; 36: 513-520
        • Schwartz P.J.
        • Malliani A.
        Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long QT syndrome.
        Am Heart J. 1975; 89: 45-50
        • Abildskov J.A.
        Adrenergic effects on the QT interval of the electrocardiogram.
        Am Heart J. 1976; 92: 210-216
        • Endresen K.
        • Amlie J.P.
        Effects of propranolol on ventricular repolarization in man.
        Eur J Clin Pharmacol. 1990; 39: 123-125
        • Mesquita E.T.
        • Deus F.C.
        • Guedes C.R.
        • Maia E.R.
        • Subieta C.G.
        • Villacorta H.
        • et al.
        Effects of propranolol on the QT dispersion in congestive heart failure.
        Arq Bras Cardiol. 1999; 73: 295-298
        • Stramba-Badiale M.
        • Goulene K.
        • Schwartz P.J.
        Effects of beta-adrenergic blockade on dispersion of ventricular repolarisation in newborn infants with prolonged QT interval.
        Am Heart J. 1997; 134: 406-410
        • Burroughs A.K.
        • Patch D.
        Primary preventions of bleeding from esophageal varices.
        N Engl J Med. 1999; 340: 1033-1035
        • D'Amico G.
        • Pagliaro L.
        • Bosch J.
        Pharmacological treatment of portal hypertension: an evidence-based approach.
        Semin Liver Dis. 1999; 19: 475-505
        • Bendtsen F.
        • Henriksen J.H.
        • Sørensen T.I.A.
        Propranolol and haemodynamic response in cirrhosis.
        J Hepatol. 1991; 13: 144-148
        • Møller S.
        • Becker U.
        • Schifter S.
        • Abrahamsen J.
        • Henriksen J.H.
        Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis.
        J Hepatol. 1996; 25: 316-328
        • Møller S.
        • Hansen E.F.
        • Becker U.
        • Brinch K.
        • Henriksen J.H.
        • Bendtsen F.
        Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
        Liver. 2000; 20: 51-59
        • Hansen E.F.
        • Bendtsen F.
        • Brinch K.
        • Møller S.
        • Henriksen J.H.
        • Becker U.
        Endoscopic Doppler ultrasound for measurement of azygos blood flow.
        Scand J Gastroenterol. 2001; 36: 318-325
        • Christensen P.K.
        • Gall M.-A.
        • Major-Pedersen A.
        • Sato A.
        • Rossing P.
        • Breum L.
        • et al.
        QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes.
        Scand J Clin Lab Invest. 2000; 60: 323-332
        • Puthumana L.
        • Chaudhry V.
        • Thuluvath P.J.
        Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis.
        J Hepatol. 2001; 35: 733-738
        • Garcia-Tsao G.
        • Grace N.D.
        • Groszmann R.J.
        • Conn H.O.
        • Bermann M.M.
        • Patrick M.J.
        • et al.
        Short-term effects of propranolol on portal venous pressure.
        Hepatology. 1986; 6: 101-106
        • Milne J.R.
        • Camm A.J.
        • Ward D.E.
        • Spurrell R.A.
        Effect of intravenous propranolol on QT interval. A new method of assessment.
        Br Heart J. 1980; 43: 1-6
        • Tonkin A.M.
        • Tornos P.
        • Heddle W.F.
        • Rapp H.
        Autonomic effects on the human cardiac conduction system. Evaluation by intracardiac electrocardiography and programmed stimulation techniques.
        Br Heart J. 1980; 44: 168-174
        • Puddu P.E.
        • Jouve R.
        • Mariotti S.
        • Giampaoli S.
        • Lanti M.
        • Reale A.
        • Menotti A.
        Evaluation of 10 QT prediction formulas in 881 middle-aged men from the seven countries study: emphasis on the cubic root Fridericia's equation.
        J Electrocardiol. 1988; 21: 219-229
        • Ahnve S.
        • Vallin H.
        Influence of heart rate and inhibition of autonomic tone on the QT interval.
        Circulation. 1982; 65: 435-439
        • Zavecz J.H.
        • Bueno O.
        • Maloney R.E.
        • O'Donnell J.M.
        • Roerig S.C.
        • Battarbee H.D.
        Cardiac excitation–contraction coupling in the portal hypertensive rat.
        Am J Physiol (Gastrointest). 2000; 279: G28-G39
        • Witchel H.J.
        • Hancox J.C.
        Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current.
        Clin Exp Pharmacol Physiol. 2000; 10: 753-766
        • Cappato R.
        • Alboni P.
        • Pedroni P.
        • Gilli G.
        • Antonioli G.E.
        Sympathetic and vagal influences on rate-dependent changes of QT interval in healthy subjects.
        Am J Cardiol. 1991; 68: 1188-1193
        • Ouriel K.
        • Moss A.J.
        Long QT syndrome: an indication for cervicothoracic sympathectomy.
        Cardiovasc Surg. 1995; 3: 475-478
        • Merz C.N.
        • Pardo Y.
        Mental versus physical stress, QT prolongation, and the autonomic nervous system.
        Circulation. 2000; 101: E213-E214
        • Andreu V.
        • Perello A.
        • Moitinho E.
        • Escorsell A.
        • Garcia-Pagan J.C.
        • Bosch J.
        • Rodes J.
        Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
        J Hepatol. 2002; 36: 356-361
        • MERIT-HF
        Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure.
        Lancet. 1999; 353: 2001-2007
        • CIBIS-II
        The cardiac insufficiency bisoprolol study II. A randomised trial.
        Lancet. 1999; 353: 9-13
        • Honig P.
        • Wortham D.
        • Zamani K.
        • Conner D.P.
        • Mullin J.C.
        • Cantilena L.R.
        Terfenadine–ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.
        J Am Med Assoc. 1993; 269: 1513-1518